Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

DIAGNOSIS

Genetic risk scores in inflammatory arthritis: a new era?

Early diagnosis of immune-mediated arthropathies is important for early and effective treatment, but often relies on clinical expertise. Can the use of a new genetic risk score help rule out and prioritize certain diagnoses? And does this score add any clinical utility to current clinical diagnostic pathways?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Knevel, R. et al. Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis. Sci. Transl Med. 12, eaay1548 (2020).

    Article  Google Scholar 

  2. Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013).

    Article  CAS  Google Scholar 

  3. Rudwaleit, M., van der Heijde, D., Khan, M. A., Braun, J. & Sieper, J. How to diagnose axial spondyloarthritis early. Ann. Rheum. Dis. 63, 535–543 (2004).

    Article  CAS  Google Scholar 

  4. Shovman, O. et al. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Clin. Dev. Immunol. 12, 197–202 (2005).

    Article  CAS  Google Scholar 

  5. Thomas, G. P. et al. Genetic diagnostic profiling in axial spondyloarthritis: a real world study. Clin. Exp. Rheumatol. 35, 229–233 (2017).

    PubMed  Google Scholar 

  6. Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173–1186 (2014).

    Article  CAS  Google Scholar 

  7. Li, Z. et al. Genetic risk score prediction in ankylosing spondylitis. Arthritis Rheum. 70, 1–3553 (2018).

    CAS  Google Scholar 

  8. Stuart, P. E. et al. Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am. J. Hum. Genet. 97, 816–883 (2015).

    Article  CAS  Google Scholar 

  9. Ge, T., Chen, C. Y., Ni, Y., Feng, Y. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).

    Article  Google Scholar 

  10. Rostami, S. et al. Prediction of ankylosing spondylitis in the population-based HUNT study by a genetic risk score combining 110 SNPs of genome-wide significance. J. Rheumatol. 47, 204–210 (2020).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew A. Brown.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brown, M.A., Aletaha, D. Genetic risk scores in inflammatory arthritis: a new era?. Nat Rev Rheumatol 16, 545–546 (2020). https://doi.org/10.1038/s41584-020-0473-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-020-0473-6

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing